316
Views
50
CrossRef citations to date
0
Altmetric
Research Article

Inflammatory bowel disease: clinics and pathology. Do inflammatory bowel disease and periodontal disease have similar immunopathogeneses?

Pages 235-243 | Published online: 02 Jul 2009

References

  • Rutgeerts P, Vermeire S. Clinical value of the detection of antibodies in the serum for diagnosis and treatment of inflammatory bowel disease. Gastroenterology 1998;115:1006 �9.
  • Panaccione R, Sandborn WJ. Is antibody testing for inflammatory bowel disease clinically useful? Gastroenterology 1999;116: 1001•3.
  • Shivananda S, Lennard-Jones J, Logan R, Fear N, Price A, Carpenter L, et al. Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD). Gut 1996;39:690 �7.
  • Bernstein CN, Blanchard JF, Rawsthorne P, Wajda A. Epidemiology of Crohn�s disease and ulcerative colitis in a central Canadian province: a population-based study. Am J Epidemiol 1999;149:916 �24.
  • Brandtzaeg, Farstad IN, Johansen F-E, Morton HC, Norderhaug IN, Yamanaka T. The B-cell system of human mucosae and exocrine glands. Immunol Rev 1999;171:45•87.
  • Brandtzaeg P, Halstensen TS, Kett K. Immunopathology of inflammatory bowel disease. In:.MacDermott RP, Stenson WF, editors. Inflammatory bowel disease. Current topics in gastro-enterology (Series editor: Zakim D). London: Elsevier, 1992. p. 95•136.
  • Brandtzaeg P, Kraus FW. Autoimmunity and periodontal disease. Odontol Tidskr (Scand J Dent Res) 1965;73:281 �393.
  • Brandtzaeg P. Local factors of resistance in the gingival area. J Periodont Res 1966;1:19•42.
  • Brandtzaeg P. Local formation and transport of immunoglobu-lins related to the oral cavity. In: MacPhee IT, editor. Host resistance to commensal bacteria. London: Churchill-Livingstone; 1972. p. 116•50.
  • Brandtzaeg P. Immunology of inflammatory periodontal lesions. Int Dent J 1973;23:438•54.
  • Brandtzaeg P. Immunoglobulin systems of oral mucosa and saliva. In: Dolby AE, editor. Oral mucosa in health and disease. Oxford: Blackwell Scientific Publications; 1975. p. 137•213.
  • Brandtzaeg P, Tolo K. Immunoglobulin systems of the gingiva. In: Lehner T, editor. The borderline between caries and periodontal disease. London: Academic Press; 1977. p. 145•89.
  • Seymour GJ. Possible mechanisms involved in the immuno-regulation of chronic inflammatory periodontal disease. J Dent Res 1987;66:2•9.
  • Seymour GJ, Powell RN, Davies WI. The immunopathogenesis of progressive chronic inflammatory periodontal disease. J Oral Pathol 1979;8:249 �65.
  • Roitt I, Brostoff J, Male D. Immunology. 5th ed. London: Mosby; 1998. p. 423.
  • Fiocchi C. Inflammatory bowel disease: etiology and pathogen-esis. Gastroenterology 1998;115:182 �205.
  • Brandtzaeg P, Haraldsen G, Helgeland L, Nilsen EM, Rugtveit J. New insights into the immunopathology of human inflammatory bowel disease. Drugs Today 1999;35 Suppl A:33•70.
  • Dombrowicz D, Nutten S, Desreumaux P, Neut C, Torpier G, Peeters M, et al. Role of the high affinity immunoglobulin E receptor in bacterial translocation and intestinal inflammation. J Exp Med 2001;193:25•34.
  • Buckley CD, Pilling D, Lord JM, Akbar AN, Scheel-Toellner D, Salmon M. Fibroblasts regulate the switch from acute resolving to chronic persistent inflammation. Trends Immunol 2001;22: 199•204.
  • Listgarten MA. Nature of periodontal diseases: pathogenic mechanisms. J Periodontal Res 1987;22:172 �8.
  • Reinholdt J, Kilian M. Interference of IgA protease with the effect of secretory IgA on adherence of oral streptococci to saliva-coated hydroxyapatite. J Dent Res 1987;66:492 �7.
  • Tolo K, Schenck K, Johansen JR. Activity of human serum immunoglobulins to seven anaerobic oral bacteria before and after periodontal treatment. J Periodont Res 1982;17:481 �3.
  • Ebersole JL, Taubman MA, Smith DJ, Socransky SS. Humoral immune responses and diagnosis of human periodontal disease. J Periodont Res 1982;17:478 �80.
  • Tolo K, Brandtzaeg P. Relation between periodontal disease activity and serum antibody titres to oral bacteria. In: Genco RJ, Mergenhagen SE, editors. Host-parasite interactions in period-ontal diseases. Washington (DC): American Society for Microbiology; 1982. p. 270•82.
  • Ebersole JL, Frey DE, Taubman MA, Haffajee AD, Socransky SS. Dynamics of systemic antibody responses in periodontal disease. J Periodontal Res 1987;22:184 �6.
  • Ebersole JL, Cappelli D, Steffen MJ. Characteristics and utilization of antibody measurements in clinical studies of periodontal disease. J Periodontol 1992;63:1110 �6.
  • Mooney J, Adonogianaki E, Riggio MP, Takahashi K, Haerian A, Kinane DF. Initial serum antibody titer to Porphyromonas gingivalis influences development of antibody avidity and success of therapy for chronic periodontitis. Infect Immun 1995;63: 3411•6.
  • Brandtzaeg P, Tolo K. Mucosal penetrability enhanced by serum-derived antibodies. Nature 1977;266:262 �3.
  • Brandtzaeg P, Tolo K. Influence of parenteral immunization in rabbits on the penetrability of oral mucosa for macromolecules. Adv Exp Med Biol 1978;107:227•32.
  • Stenson WF. Animal models of inflammatory bowel disease. In: Taragan R, Shanahan F, editors. Inflammatory bowel disease� from bench to bedside. London: Williams & Wilkins; 1994. p. 180•92.
  • Schonfeld SE, Kagan JM. Specificity of gingival plasma cells for bacterial somatic antigens. J Periodontal Res 1982;17:60 �9.
  • Smith DJ, Gadalla LM, Ebersole JL, Taubman MA. Gingival crevicular fluid antibody to oral microorganisms. III. Association of gingival homogenate and gingival crevicular fluid antibody levels. J Periodontal Res 1985;20:357 �67.
  • Macpherson A, Khoo UY, Forgacs I, Philpott-Howard J, Bjarnason I. Mucosal antibodies in inflammatory bowel disease are directed against intestinal bacteria. Gut 1996;38:365 �75.
  • Brandtzaeg P, Haraldsen G, Rugtveit J. Immunopathology of human inflammatory bowel disease. Springer Semin Immuno-pathol 1997;18:555 �89.
  • Halstensen TS, Mollnes TE, Garred P, Brandtzaeg P. Terminal complement complex (TCC) and S-protein (vitronectin) are located on follicular dendritic cells (FDC) in human lymphoid tissues. Immunology 1988;65:193 �7.
  • Theilade E. The non-specific theory in microbial etiology of inflammatory periodontal diseases. J Clin Periodontol 1986;13: 905•11.
  • Brandtzaeg P, Farstad IN, Helgeland L. Phenotypes of T cells in the gut. In: Mucosal T cells. Chem Immunol 1998;71:1•26.
  • Brandtzaeg P, Farstad IN, Haraldsen G. Regional specialization in the mucosal immune system: primed cells do not always home along the same track. Immunol Today 1999;20:267 �77.
  • Kinane DF, Lappin DF, Koulouri O, Buckley A. Humoral immune responses in periodontal disease may have mucosal and systemic immune features. Clin Exp Immunol 1999;115:534 �41.
  • Brandtzaeg P. Autoimmunity and ulcerative colitis: can two enigmas make sense together? Gastroenterology 1995;109:307 � 12.
  • Hershberg RM, Mayer LF. Antigen processing and presentation by intestinal epithelial cells�polarity and complexity. Immunol Today 2000;21:123•8.
  • Brandtzaeg P. Nature and function of gastrointestinal antigen-presenting cells. Allergy 2001;56 Suppl 67:16•20.
  • Neurath MF, Finotto S, Fuss I, Boirivant M, Galle PR, Strober W. Regulation of T-cell apoptosis in inflammatory bowel disease: to die or not to die, that is the mucosal question. Trends Immunol 2001;22:21•6.
  • Nagler-Anderson C. Tolerance and immunity in the intestinal immune system. Crit Rev Immunol 2000;20:103•20.
  • Bu�ller HA. Inflammatory bowel disease and related models. In: Delvin EE, Lentze MJ, editors. Gastrointestinal functions. Vol. 46, Nestle� Nutrition Workshop Series, Pediatric Program, Nestec Ltd. Philadelphia: Vevey/Lippincott Williams & Wilkins; 2001. p. 285•302.
  • MacDonald TT, Monteleone G, Pender SL. Recent developments in the immunology of inflammatory bowel disease. Scand J Immunol 2000;51:2•9.
  • Winkler JR, Murray PA. Periodontal disease. A potential intraoral expression of AIDS may be rapidly progressive periodontitis. CDA J 1987;15:20 �4.
  • Brandtzaeg P. Role of the immune system�dangers of a nonholistic approach in explaining health and disease. In: Guggenheim B, editor. Periodontology today. Basel: Karger; 1988. p. 196•208.
  • Hooper LV, Wong MH, Thelin A, Hansson L, Falk PG, Gordon JI. Molecular analysis of commensal host-microbial relationships in the intestine. Science 2001;291:881 �4.
  • Hyams JS, Davis P, Grancher K, Lerer T, Justinich CJ, Markowitz J. Clinical outcome of ulcerative colitis in children. J Pediatr 1996;129:81•8.
  • Sobin LH. A pathology primer in verse. London: Lewis HK; 1978. p. 249•65.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.